Zanubrutinib-based Maintenance Therapy of Newly Diagnosed DLBCL With Initial Remission
Zanubrutinib-based Maintenance Therapy of Newly Diagnosed DLBCL With Initial Remission
Not yet recruiting · NCT06669143 · Registry updated 2024-11-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Zanubrutinib-based Maintenance Therapy of Newly Diagnosed DLBCL With Initial Remission | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Not yet recruiting | Phase 2 | 2024-11-01 | NCT06669143 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ruijin Hospital | 454 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||